 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 4 | 6 | | 1996 | 1 | 1 | 2 | | 1997 | 0 | 4 | 4 | | 1998 | 2 | 4 | 6 | | 1999 | 2 | 3 | 5 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 3 | 5 | | 2002 | 0 | 2 | 2 | | 2003 | 2 | 6 | 8 | | 2004 | 1 | 6 | 7 | | 2005 | 2 | 4 | 6 | | 2006 | 3 | 5 | 8 | | 2007 | 4 | 6 | 10 | | 2008 | 3 | 6 | 9 | | 2009 | 2 | 11 | 13 | | 2010 | 2 | 5 | 7 | | 2011 | 6 | 3 | 9 | | 2012 | 5 | 4 | 9 | | 2013 | 4 | 4 | 8 | | 2014 | 3 | 7 | 10 | | 2015 | 8 | 6 | 14 | | 2016 | 2 | 6 | 8 | | 2017 | 5 | 13 | 18 | | 2018 | 6 | 13 | 19 | | 2019 | 8 | 8 | 16 | | 2020 | 13 | 15 | 28 | | 2021 | 23 | 23 | 46 | | 2022 | 2 | 31 | 33 | | 2023 | 0 | 12 | 12 | | 2024 | 7 | 15 | 22 | | 2025 | 10 | 9 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Yee DS, Davies JP, VanBlargan LA, Rahmberg AR, Burgomaster KE, Brooks K, Flynn JK, Shue B, Ortiz AM, Schaughency P, Best SM, Pierson TC, Brenchley JM. Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species. Sci Adv. 2025 Sep 19; 11(38):eadx9405.
-
Swingle KL, Hamilton AG, Han X, Liao KC, Safford HC, Thatte AS, Geisler HC, Xu J, Saw TY, Wan Y, Mitchell MJ. Circular RNA lipid nanoparticle vaccine against SARS-CoV-2. Proc Natl Acad Sci U S A. 2025 Sep 23; 122(38):e2505718122.
-
Ouyang WO, Lv H, Liu W, Lei R, Mou Z, Pholcharee T, Talmage L, Tong M, Ji W, Wang Y, Dailey KE, Gopal AB, Choi D, Ardagh MR, Rodriguez LA, Guthmiller JJ, Dai X, Wu NC. High-throughput synthesis and specificity characterization of natively paired influenza hemagglutinin antibodies with oPool+ display. Sci Transl Med. 2025 Sep 03; 17(814):eadt4147.
-
Baum HE, Santopaolo M, Francis O, Milodowski EJ, Entwistle K, Oliver E, Hitchings B, Diamond D, Thomas AC, Mitchell RE, Kibble M, Gupta K, Di Bartolo N, Klenerman P, Brown A, Morales-Aza B, Oliver J, Berger I, Toye AM, Finn A, Goenka A, Davidson AD, Ring S, Molloy L, Lewcock M, Northstone K, Roth F, Timpson NJ, Wooldridge L, Halliday A, Rivino L. Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. J Infect Dis. 2025 Aug 14; 232(2):e327-e340.
-
Randolph T, Coleman H, Rauch AM, Hubert H, Witeof AE, Walker KD, Funke HH, Garcea RL. Superior immune responses from thermostable, single-administration rabies vaccines prepared using atomic layer deposition. J Pharm Sci. 2025 Sep; 114(9):103936.
-
Knowlton KU, Siegel LK, Barkauskas CE, Bhagani S, Dharan NJ, Gardner EM, Gottlieb RL, Helleberg M, Highbarger HC, Holland TL, Heerfordt CK, Lazarte S, Leither LM, Lutaakome J, Ardelt M, Mylonakis E, Ong SWX, Overcash JS, Taha H, Tien PC, Trautner BW, Vallee D, Weintrob AC, Touloumi G, Babiker AG. Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials. PLoS Med. 2025 Jul; 22(7):e1004616.
-
Nakarin F, Sprenger KG. A paradigm shift in simulating affinity maturation to elicit broadly neutralizing antibodies. Front Immunol. 2025; 16:1627674.
-
Janoff EN, Shih MC, Donskey C, Belitskaya-Levy I, Brau N, Rodriguez-Barradas MC, Chan E, Zimmerman P, Miller EK, Vaughan LB, Daniel Markley J, Goldberg AM, Sriram P, Anzueto A, Uyeda L, Zehm L, Wills A, Hutchinson C, Jones L, Peterson D, Ringer RJ, Dumont L, Gleason T, Bonomo RA, Curtis JL, Brown ST. Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1). J Med Virol. 2025 May; 97(5):e70349.
-
Godin A, Brickley EB, Connor RI, Wieland-Alter WF, Ackerman ME, Weiner JA, Modlin J, Arita M, Bandyopadhyay AS, Gast C, Sáez-Llorens X, Rüttimann RW, Van Damme P, De Coster I, Wright PF. Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials. Lancet Microbe. 2025 Jun; 6(6):101028.
-
Fullerton HJ, Hills NK, Wintermark M, Dlamini N, Fox CK, Cummings DD, Bernard TJ, Beslow LA, Sun LR, Grose C, Norris PJ, Di Germanio C. Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment. Stroke. 2025 May; 56(5):1200-1209.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|